Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXUVIA: Balovaptan in adults with PTSD
NCT05401565Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of balovaptan in post-traumatic stress disorder (PTSD), sponsored by Roche. Started Aug 2022; status: completed.
02
Drugs
balovaptan
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05401565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05401565.